Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Applied Therapeutics Inc (APLT)

Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 66,527
  • Shares Outstanding, K 141,576
  • Annual Sales, $ 460 K
  • Annual Income, $ -105,620 K
  • EBIT $ -104 M
  • EBITDA $ -103 M
  • 60-Month Beta 1.82
  • Price/Sales 136.19
  • Price/Cash Flow N/A
  • Price/Book 1.69
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.73
  • Most Recent Earnings $-0.15 on 05/13/25
  • Next Earnings Date 08/06/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 584.33% ( +68.04%)
  • Historical Volatility 100.60%
  • IV Percentile 93%
  • IV Rank 56.21%
  • IV High 986.44% on 07/02/25
  • IV Low 68.08% on 07/25/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 46
  • Volume Avg (30-Day) 242
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 24,995
  • Open Int (30-Day) 23,302

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.17
  • Number of Estimates 2
  • High Estimate -0.16
  • Low Estimate -0.18
  • Prior Year -0.13
  • Growth Rate Est. (year over year) -30.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2998 +54.07%
on 06/23/25
0.4787 -3.51%
on 07/18/25
+0.1114 (+31.78%)
since 06/18/25
3-Month
0.2998 +54.07%
on 06/23/25
0.6380 -27.60%
on 05/16/25
+0.1289 (+38.71%)
since 04/17/25
52-Week
0.2950 +56.58%
on 04/16/25
10.6237 -95.65%
on 11/11/24
-4.7981 (-91.22%)
since 07/18/24

Most Recent Stories

More News
Applied Therapeutics Announces Key Leadership Appointments

APLT : 0.4619 (-1.70%)
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

APLT : 0.4619 (-1.70%)
Applied Therapeutics Reports First Quarter 2025 Financial Results

APLT : 0.4619 (-1.70%)
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

APLT : 0.4619 (-1.70%)
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

APLT : 0.4619 (-1.70%)
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

APLT : 0.4619 (-1.70%)
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

APLT : 0.4619 (-1.70%)
Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality

APLT : 0.4619 (-1.70%)
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT

New York, New York--(Newsfile Corp. - January 2, 2025) - Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action...

APLT : 0.4619 (-1.70%)
Applied Therapeutics Appoints John H. Johnson as Executive Chairman

APLT : 0.4619 (-1.70%)

Business Summary

Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet medical need. The company's product candidate consists of AT-001, for the treatment of Diabetic Cardiomyopathy; AT-007, for the treatment of Galactosemia and AT-003, for the treatment...

See More

Key Turning Points

3rd Resistance Point 0.5123
2nd Resistance Point 0.4955
1st Resistance Point 0.4787
Last Price 0.4619
1st Support Level 0.4451
2nd Support Level 0.4283
3rd Support Level 0.4115

See More

52-Week High 10.6237
Fibonacci 61.8% 6.6781
Fibonacci 50% 5.4594
Fibonacci 38.2% 4.2406
Last Price 0.4619
52-Week Low 0.2950

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar